Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00521066 · ClinicalTrials.gov registry record
GYNECARE PROSIMA* Pelvic Floor Repair System for Pelvic Organ Prolapse
A clinical trial, sponsored by Ethicon.
- Completed
- Registry status
- 150
- Enrollment target
NCT00521066: Completed study, sponsored by Ethicon.
NCT00521066 is a clinical trial that has completed, run by Ethicon. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00521066 has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to is to evaluate the success of the GYNECARE PROSIMA\* system in women with symptoms for pelvic organ prolapse (POP) requiring surgical correction of POP. (\*TRADEMARK)
Primary Outcome
Success is determined by achievement of an overall POP-Q score of ICS Stage ≤1, without further re-intervention for POP.
Interventions
- DEVICE GYNECARE PROSIMA* Pelvic Floor Repair System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-06 |
What the finished NCT00521066 record still lists
NCT00521066 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which GYNECARE PROSIMA* Pelvic Floor Repair System is the first listed.
NCT00521066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00521066 about?
NCT00521066 is a clinical study titled "GYNECARE PROSIMA* Pelvic Floor Repair System for Pelvic Organ Prolapse". The purpose of this study is to is to evaluate the success of the GYNECARE PROSIMA\* system in women with symptoms for pelvic organ prolapse (POP) requiring surgical correction of POP. (\*TRADEMARK)
What is the current status of trial NCT00521066?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2007-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00521066?
The interventions under investigation include: GYNECARE PROSIMA* Pelvic Floor Repair System (DEVICE).
Who is sponsoring clinical trial NCT00521066?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia